Kaken Pharmaceutical Co., Ltd.

KKPCF · OTC
Analyze with AI
3/31/2025
3/31/2024
3/31/2023
3/31/2022
Assets
Cash & Equivalents$54,093$50,625$59,561$61,025
Short-Term Investments$15,992$14,699$14,699$13,599
Receivables$21,178$23,744$19,268$20,260
Inventory$19,020$17,167$15,563$14,980
Other Curr. Assets$1,094$739$812$749
Total Curr. Assets$111,377$106,974$109,903$110,613
Property Plant & Equip (Net)$27,629$25,355$25,498$25,734
Goodwill$14,035$0$0$0
Intangibles$5,254$7,462$6,741$8,236
Long-Term Investments$0$5,833$20,312$18,871
Tax Assets$4,065$2,590$3,873$1,725
Other NC Assets$28,060$23,406-$1-$1
Total NC Assets$79,043$64,646$56,423$54,565
Other Assets$2$3$2$3
Total Assets$190,422$171,623$166,328$165,181
Liabilities
Payables$8,186$6,976$6,219$5,939
Short-Term Debt$3,850$3,850$3,850$3,850
Tax Payable$7,285$76$2,004$2,436
Deferred Revenue$0$0$9,389$7,373
Other Curr. Liab.$11,033$8,122$8,765$6,824
Total Curr. Liab.$30,354$19,024$20,838$19,049
LT Debt$0$0$0$0
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$1,514$1,947$1,771$2,229
Other NC Liab.$5,920$6,897$6,884$5,580
Total NC Liab.$7,434$8,844$8,655$7,809
Other Liabilities$0$0$0$0
Cap. Leases$0$0$0$0
Total Liabilities$37,788$27,868$29,493$26,858
Equity
Pref Stock$0$0$0$132,893
Common Stock$23,853$23,853$23,853$23,853
Retained Earnings$135,242$128,506$126,135$126,347
AOCI$0$0$4,889$4,852
Other Equity-$6,461-$8,604-$18,620-$12,455
Total Equity$152,634$143,755$136,257$137,745
Supplemental Information
Minority Interest$0$0$578$578
Total Liab. & Tot. Equity$190,422$171,623$166,328$165,181
Net Debt-$50,243-$46,775-$55,711-$57,175